Intellectual Property Rights, Genetic Use Restriction Technologies (GURTs), and Strategic Behavior

This article discusses the mutual reinforcement effects of IPRs and biotechnology in recent years, and review the development of GURTs and how the major agricultural biotechnology companies behave in that regard. Both proponents and opponents of GURTs made strong arguments based on speculations. We discuss the major arguments by both sides, and argue the possible strategic use of bundling and licensing strategy by the biotech giants, because GURTs make it possible for a seed to be marketed as a vector of trait options. We also examine the validity of two major implicit assumptions held by those opposing GURTs: patenting does not affect the monopoly power of GURTs; and GURTs would take over the GM seed market.

Issue Date:
Publication Type:
Conference Paper/ Presentation
DOI and Other Identifiers:
Record Identifier:
PURL Identifier:
Total Pages:
Replaced with revised version of paper 07/30/06.
Series Statement:
Selected Paper 156058

 Record created 2017-04-01, last modified 2020-10-28

Download fulltext

Rate this document:

Rate this document:
(Not yet reviewed)